泌尿道移形細胞癌轉移至皮膚之病例不多。膀胱移形細胞癌轉移至皮膚之發生率為百分之零點二至二之間。腎盂移形細胞癌轉移至皮膚之發生率不明。大部分皮膚轉移在原發癌治療後半年至數年之間發生。皮膚轉移癌之治療模式包括手術，放射治療及化學治療。化學治療包括M-VAC（Methrotrexate, Vinblastine, Adriamycin及Cisplatin）或Gemcitabine。泌尿道移形細胞癌轉移至皮膚之預後極差。

It is rare to see skin metastasis originated from the transitional cell carcinoma (TCC) of urinary tract. The incidence of skin metastasis from TCC of urinary bladder generally falls in the range from 0.2 to 2%, however, that of the TCC of renal pelvis metastasis to skin remains unknown. Most of the skin metastases occur at a time period from six months to several years after the diagnosis of the primary tumor. The treatment modalities adapted on the treatment of cutaneous metastasis include surgery, radiation therapy and chemotherapy with M-VAC (methrotrexate, vinblastin, adriamycin and cisplatin) or gemcitabine. We have seen a dismal prognosis on a male patient with skin metastasis from TCC of urinary tract.